This category celebrates advancements in technologies, products, processes, and services designed to mitigate the effects of global healthcare emergencies on individuals, patients, healthcare professionals, and communities. It recognises innovations such as drug and device development, rapid response initiatives, medical equipment, and the introduction of services, solutions, and resources aimed at addressing the impact of past and potential healthcare crises.

This category celebrates innovation in technologies, products, processes, and services related to the development and manufacture of active pharmaceutical ingredients. It encompasses but is not limited to, advancements in synthesis, characterisation, scale-up, software and database development, and bulk manufacturing. 

This category celebrates innovation in technologies, products, processes, and services related to the formulation of drug products. It includes but is not limited to, advancements in excipients, finished dosage forms, OTC products, novel software and digitalisation, process development, overcoming formulation challenges, bioavailability enhancement, drug targeting, controlled release, and stabilisation technologies.

This category celebrates innovation in technologies, processes, and services for the manufacture of solid, semi-solid, parenteral, inhalation, or other dosage forms. It includes but is not limited to, advancements in equipment, manufacturing approaches, digitalisation, manufacturing processes, facilities, tech transfer, and process controls. We welcome entries from both small and large molecule manufacturing. 

This category celebrates innovation in technologies, products, solutions, processes, and services related to drug delivery, routes of administration, and device innovation. It includes but is not limited to, advancements in inhalers, auto-injectors, pre-filled syringes, patches, combination products, intelligent packaging, and connected devices.

This category celebrates innovation in technologies, products, processes, equipment, and services for primary, secondary, and tertiary packaging solutions, as well as the packaging and assembly of finished drug products. It includes but is not limited to, advancements in vials, ampules, blister packs, cartons, containers, tamper-proof packaging, labeling systems, track and trace technologies, anti-counterfeiting measures, and solutions that prioritise patient centricity and adherence.

This category celebrates innovation in technologies, products, processes, and services that ensure the safe handling, security, and tracking of drug substances, raw materials, and finished drug products. It includes but is not limited to, advancements in supply chain optimisation, audits, temperature-controlled logistics, transport services, shipping and storage, anti-counterfeiting measures, inventory management, demand forecasting, and distribution channels.

This category recognises innovation in sustainable manufacturing, production, or development within the pharmaceutical industry. It includes but is not limited to, innovative approaches to reducing environmental impact, waste, and carbon emissions; energy and utility-saving solutions; sustainable and collaborative product development; plastic reduction; improved recyclability and lifecycle management; the implementation of circular economy initiatives; innovative use of materials; safeguarding workers; and programs or initiatives aimed at improving diversity and inclusion.

This category recognizes innovation in technologies, products, processes, and services that support and ensure compliance with regulatory standards, mandates, and guidelines. Entries may include, but are not limited to, consulting services, industry consortia and collaborative initiatives, reference standards, educational programs, case studies, as well as cutting-edge technologies, platforms, and equipment designed to streamline regulatory adherence.

This award recognises outstanding leadership within the pharma industry. We invite C-Suite executives from SMEs, large pharma/biopharma companies, and service providers to apply. The jury will be looking for examples of exceptional leadership, which may include achievements in areas such as financial performance, product success, global reach, leadership skills, management capability, charitable initiatives, sustainability, regulatory compliance, profitability, vision, marketing, acquisitions, corporate strategy, and financing.

This category recognises Start-Ups and SMEs that are driving value and innovation across the pharma value chain. We are seeking entries that showcase a clear promise of innovation, growth, or sustainable development in the pharmaceutical industry. Understanding that Start-Ups may be at various stages of development, we welcome entries across proof of concept, prototype, or commercialized stages.

This award celebrates companies, individuals, and initiatives that prioritise philanthropic, ethical, and community-driven efforts. We welcome entries that focus on patient engagement and centricity, promote corporate social responsibility, and improve healthcare accessibility or equity.

Each generation brings a new perspective, and this award recognises the rising stars who are shaping the future of pharma with fresh approaches. We invite applications from candidates with at least five years of experience within a pharma, biopharma company, academic institution, or research setting. Entrants must be no older than 35 by the time of the Awards ceremony on 28th October 2025.